We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Archrock
AROC
$5.85B
| $624K | ﹤0.01% |
+60,859
| New | +$600K |
|
1202
OneSpaWorld
OSW
$2.73B
| $618K | ﹤0.01% |
+51,063
| New | +$590K |
|
1203
Credit Acceptance
CACC
$6.05B
| $605K | ﹤0.01% |
1,192
-17,891
| -94% | -$8.37M |
|
1204
HDFC Bank
HDB
$119B
| $599K | ﹤0.01% |
+17,180
| New | +$579K |
|
1205
Ralph Lauren
RL
$23.1B
| $596K | ﹤0.01% |
4,832
-50,616
| -91% | -$5.84M |
|
1206
Playtika
PLTK
$961M
| $585K | ﹤0.01% |
+50,468
| New | +$547K |
|
1207
NovaGold Resources
NG
$3.4B
| $577K | ﹤0.01% |
144,622
-155,880
| -52% | -$838K |
|
1208
WaFd
WAFD
$2.81B
| $573K | ﹤0.01% |
21,612
-143,904
| -87% | -$3.98M |
|
1209
California Resources
CRC
$4.69B
| $572K | ﹤0.01% |
+12,634
| New | +$513K |
|
1210
Magnite
MGNI
$3.53B
| $571K | ﹤0.01% |
+41,812
| New | +$465K |
|
1211
Universal Health Services
UHS
$10.1B
| $568K | ﹤0.01% |
3,603
+1,463
| +68% | +$204K |
|
1212
Allstate
ALL
$65.9B
| $568K | ﹤0.01% |
+5,210
| New | +$591K |
|
1213
Blackbaud
BLKB
$2.1B
| $566K | ﹤0.01% |
+7,958
| New | +$559K |
|
1214
Workiva
WK
$4.01B
| $556K | ﹤0.01% |
+5,467
| New | +$526K |
|
1215
Palomar
PLMR
$3.37B
| $555K | ﹤0.01% |
9,561
-2,823
| -23% | -$151K |
|
1216
Mesa Laboratories
MLAB
$633M
| $553K | ﹤0.01% |
+4,302
| New | +$656K |
|
1217
Paylocity
PCTY
$8.1B
| $544K | ﹤0.01% |
2,949
+1,114
| +61% | +$204K |
|
1218
IonQ
IONQ
$18.2B
| $544K | ﹤0.01% |
+40,179
| New | +$334K |
|
1219
Ciena
CIEN
$62.7B
| $542K | ﹤0.01% |
+12,752
| New | +$581K |
|
|
PNT
1220
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $541K | ﹤0.01% |
+59,659
| New | +$526K |
|
1221
Dole
DOLE
$1.26B
| $539K | ﹤0.01% |
+39,866
| New | +$511K |
|
1222
PDF Solutions
PDFS
$2.13B
| $538K | ﹤0.01% |
+11,934
| New | +$487K |
|
1223
Petco
WOOF
$817M
| $538K | ﹤0.01% |
+60,470
| New | +$557K |
|
1224
PRA Group
PRAA
$762M
| $537K | ﹤0.01% |
+23,520
| New | +$652K |
|
|
AJRD
1225
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $534K | ﹤0.01% |
9,732
+5,945
| +157% | +$330K |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.